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Highlights:  
 Plasma concentrations of DBP, albumin, 25(OH)D & 1,25(OH)2D exhibited significant diurnal 
rhythms (DR) 
 DRs were similar in British, Gambian and Chinese men and women aged 60 – 75 years 
 The free 1,25(OH)2D DR was attenuated compared to that of total 1,25(OH)2D 
 The magnitude of the free 25(OH)D DR was not different to that of total 25(OH)D 
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Abstract  
Vitamin D binding protein (DBP) concentration is known to influence the availability and bioactivity 
of vitamin D metabolites but its diurnal rhythm (DR), its inter-relationships with the DRs of vitamin D 
metabolites and its influence on free vitamin D metabolite concentrations are not well described.   
The DRs of plasma total 25(OH)D, total 1,25(OH)2D, DBP, albumin and calculated free 25(OH)D and 
free 1,25(OH)2D were measured in men and women aged 60-75 years and resident in the UK (n 30), 
Gambia (n 31) and China (n 30) with differences in lifestyle, dietary intake and vitamin D status.  Blood 
samples were collected every 4 hours for 24 hours and DRs statistically analysed with Fourier 
regression.  
Gambians had significantly higher plasma concentrations of vitamin D metabolites and lower albumin 
concentration compared to the British and Chinese. Significant DRs were observed for all analytes and 
calculated free vitamin D metabolites (P<0.01).  The pattern of DRs was similar between countries. The 
magnitude of the DRs of free 1,25(OH)2D was attenuated compared to that of total 1,25(OH)2D whereas 
it was not different between total and free 25(OH)D.  Relationships between the DRs were generally 
weak. There was no phase shift between 1,25(OH)2D and DBP with the strongest cross correlation at 0 
hour time lag (r=0.15, P=<0.001). In comparison, 25(OH)D correlated less well with DBP (1 hour time 
lag, r=0.07, P=0.12).   
These data demonstrate a relationship between the DRs of 1,25(OH)2D and DBP, possibly to maintain 
free 1,25(OH)2D concentrations. In contrast, the DRs of total and free 25(OH)D appeared to be less 
influenced by DBP, suggesting that DBP has comparatively less effect on 25(OH)D concentration and 
25(OH)D availability. This work highlights the importance of standardisation in timing of sample 
collection particularly for the assessment of plasma protein concentrations. 
 
Abbreviations: DBP, vitamin D binding protein; DR, diurnal rhythm; CCV%, coefficient of cyclic 
variation % 
 
Keywords: 25(OH)D, 1,25(OH)2D, Fourier regression, bioavailability, Africa, diurnal,  
 
1. Introduction 
Vitamin D is important in calcium, phosphate and bone metabolism and may be important in other 
aspects of human health.  The total plasma concentration of the pro-hormone 25-hydroxyvitamin D 
(25(OH)D) is measured to determine vitamin D status. The majority of 25(OH)D in the circulation is 
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bound to vitamin D binding protein (DBP) or albumin with only around 1% circulating in its free form. 
On the basis of the free hormone hypothesis it is this free fraction that has access to the majority of 
tissues, thus the concentration of free 25(OH)D may provide a marker of 25(OH)D availability to cells 
and tissues [1, 2].  Some tissues, including the kidney, internalise DBP-bound 25(OH)D via the plasma 
membrane transporter protein, megalin. The relative importance of bound and free 25(OH)D for 
different organ systems remains an area of active research. A stronger association between serum 
calcium, PTH, bone and vascular outcomes and inflammation with free 25(OH)D concentration are 
reported by some but not all studies (reviewed in [3, 4]). However, many of these studies were 
confounded by the use of particular assays [5].  In addition, 1,25(OH)2D, rather than 25(OH)D, is the 
biologically active vitamin D molecule that activates the vitamin D receptor (VDR) in cells.  Like 
25(OH)D, the majority of 1,25(OH)2D in the circulation is bound to DBP and some tissues internalise 
DBP-bound 1,25(OH)2D. Thus free 1,25(OH)2D concentration may provide better information on the 
systemic biological activity of 1,25(OH)2D than its total plasma concentration [6, 7]. 
There is pronounced 24-hour variation or diurnal rhythm (DR) in the plasma concentrations of calcium 
and phosphate regulating hormones, in particular PTH which is the main regulator of systemic renal 
1,25(OH)2D production [8, 9]. Reports of a DR in the plasma concentration of 1,25(OH)2D and other 
vitamin D metabolites are less consistent. This may be partly due to the potential influence of a 
simultaneous DR of DBP. The DRs of vitamin D metabolites and DBP and their inter-relationships may 
impact on the concentration and proportion of free or bound vitamin D metabolites available to tissues 
for internalisation.  The influence of this variation will depend on the extent to which cells or tissues 
rely on the megalin-mediated or megalin–independent mechanisms for vitamin D uptake and 
availability to activate the VDR.  Data on the DRs of 25(OH)D, 1,25(OH)2D and DBP are required to 
determine variations in the free fractions to understand vitamin D metabolism, particularly availability 
for extra-renal metabolism, and the potential importance of the timing of sample collections in research 
studies of clinical populations.   
Here, combining novel data on 25(OH)D and DBP with data from a previous study of 1,25(OH)2D [9], 
we describe the DRs of plasma 25(OH)D, 1,25(OH)2D, DBP, albumin and free vitamin D metabolites.  
The data were derived from studies in three different ethnic groups that allowed exploration of the 
consistency of DRs in groups despite genetic and environmental differences that influence  DBP 
subtype [10] and vitamin D status.   
2. Methods 
Descriptions of participants, study design and statistical analyses have been published previously in full 
[9] and are described in summary below. 
2.1 Study location 
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The studies were conducted at three research centres: (1) MRC Human Nutrition Research, Cambridge 
UK, (2) MRC Keneba, The Gambia and (3) Shenyang Medical College, Shenyang, PR China. The 
characteristics of each population were described previously [9, 11, 12]. The British and Chinese studies 
were performed in winter when there is no cutaneous synthesis of vitamin D.  The Gambia has two 
seasons, a ‘wet’ or ‘rainy’ season between June and October characterised by cloud and heavy rain and 
a ‘dry’ season characterised by largely clear skies and little, if any rainfall. This study was performed 
in the dry season during which there is expected to be little variation in UVB supply or potential UVB 
exposure.  The study in each country was approved by their respective Ethics committee [9] and all 
participants provided written, informed consent.  All research was performed in accordance with the 
Declaration of Helsinki.  
2.2 Study participants 
Participants were apparently healthy, free-living men and women aged 60 to 75 years recruited from 
the local community. Exclusion criteria were any known pathological disorder that may alter calcium 
or bone metabolism [11], haemoglobin < 10 g/dL and plasma creatinine > 115 μmol/L [9]. 
2.3 Study design 
This was a secondary analysis of samples and data collected in a study designed to investigate 
differences in the DRs of PTH and bone metabolism markers [9].  The sample size of 15 individuals 
per sex from the original study was based on the ability to detect a 6% difference between the peak and 
nadir of PTH concentration (significance level of 5% and power of 80%) [9].  Participants were studied 
over a 24 hour period and encouraged, as far as possible, to maintain normal activities and eating and 
sleeping routines. Sample collections were performed at standardised times at the participants’ homes 
and/or respective research centres as per the arrangements for each country [9].  Fasting blood samples 
were collected from all participants in the early morning.  Subsequent blood samples were collected in 
the non-fasting state every 4 hours. Participants were assigned to one of two groups whose blood 
collections were staggered by two hours and the data combined to derive a  group level DR (see section 
2.5 Data analysis) [9]. 
2.4 Biochemical analysis 
Plasma samples for biochemical analysis were transported from The Gambia and China on dry ice and, 
as with the UK samples, were stored at -80°C until analysis. Plasma total 25(OH)D was measured by 
Liaison (Diasorin Ltd, Dartford, UK), total 1,25(OH)2D by radioimmunoassay (IDS Ltd, Tyne and 
Wear, UK), as described previously [9] and DBP by polyclonal antibody ELISA (Immunodiagnostik 
AG (Oxford Biosystems, Oxford, UK)) and albumin with an automated colorimetric method (Kone Lab 
20i clinical chemistry, Thermo Scientific, Vantaa, Finland).  All samples were measured in duplicate 
and analysis repeated if the CV was more than 10%. Assay performance was measured using kit and 
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in-house controls and performance was in acceptable limits. External quality assurance was obtained 
through DEQAS (www.deqas.org) for plasma 1,25(OH)2D and 25(OH)D and traceable to NIST 
standards for 25(OH)D. This Diasorin Liaison assay in our lab has been calibrated against standardized 
LC-MS/MS reference measurement procedures developed by NIST and Ghent University. The 
relationship between the two methods is described by the equation: Diasorin Liaison = 1.023*LC-
MS/MS  - 2.52 nmol/l (r2=0.8751, n=186). 
 
2.5 Data analysis 
Data are presented as the mean (SD) or geometric mean (95% CI). For consistency with DR model 
parameters which are logged for analysis, baseline 25(OH)D, 1,25(OH)2D, DBP and albumin are 
presented as geometric means. Free concentrations of 25(OH)D and 1,25(OH)2D were calculated using 
published mathematical models [13] that include concentrations of total 25(OH)D, total 1,25(OH)2D, 
DBP and albumin. Group differences in baseline characteristics and early-morning fasted blood samples 
were tested by ANOVA with Scheffé post-hoc test or χ2 test. We made no adjustment for multiple 
testing.  
Fourier regression was used to model diurnal variation as previously described [9, 14].  All 
concentration data were logged before analysis and data were modelled by country.  The Fourier model 
uses two pairs of sine and cosine terms as independent predictors of the rhythm and a random effect to 
allow for individual intercepts and within-individual correlation of data from the multiple data points 
per individual.  The significance of the rhythm was determined by testing the null hypothesis that all 
Fourier coefficients were zero. Different methods are available to measure and compare the amplitudes 
of cyclic rhythms [15]. We used a method that allows the assessment and comparison of the magnitude 
of the amplitude on a common scale.  It was expressed as a mean (95% CI) coefficient of cyclic variation 
(CCV%), calculated as the square root of half the sum of the squared coefficients of the Fourier terms 
[15]. Differences in CCV% were compared between countries and between bound and free metabolites 
using the z-test.  Country differences in 24-hour means were tested by including country in a regression 
model of the plasma concentration of the analyte of interest against the sine and cosine parameters.  
Cross-correlation analysis on a per country basis was used to examine the relationship between variables 
and the strongest correlation, r, and lag time are presented.  Statistical analysis and modelling was 
performed in Stata 13 SE (Stata Corp, TX, USA) and z-tests in Microsoft Excel. 
3. Results 
Participant characteristics and measured fasting, baseline biochemistry are shown in Table 1.  
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Values are mean (SD) or geometric mean (95%). Group differences were tested by one-way ANOVA with Scheffé 
post-hoc tests or Chi-squared test. Free 25(OH)D and free 1,25(OH)2D are calculated values. Superscripts indicate 
differences between countries (B-Britain; G-Gambia; C-China); * P < 0.05, ** P < 0.001 
 
Gambians had significantly higher total 25(OH)D and total 1,25(OH)2D plasma concentrations and 
significantly lower albumin concentrations compared to the British and Chinese.  DBP was slightly 
lower in Gambians but was only significant when compared with the British (Gambia vs China, 
P=0.16).  Albumin concentration was lowest in the Gambians and highest in the Chinese and differences 
were significant between all countries. Free 25(OH)D and free 1,25(OH)2D were higher in the 
Gambians compared to the other groups and there were no differences between the British and Chinese.  
Results of the Fourier regression are shown in Figure 1 and Table 2.  The 24-hour mean concentrations 
derived from the DR analysis were generally similar to the fasting, baseline concentrations (within 0-
15%) with vitamin D metabolite concentrations consistently higher in Gambians compared to the 
British and Chinese (Table 2and Figure 1). In contrast to the fasting values, 24-hour mean 
concentrations of total 25(OH)D, DBP and albumin were higher in the British compared to the Chinese 
(Tables 1, 2).  
 
A significant DR was present for all analytes in each country, with the exception of free 25(OH)D in 
the Chinese.  Total 25(OH)D, total 1,25(OH)2D, DBP and albumin had lower values during the night 
and higher values during the day in all groups. The DR of free 1,25(OH)2D was attenuated compared 
to that of total 1,25(OH)2D as evidenced by the significantly lower CCV% (all P<0.01).  In contrast, 
the CCV%s between total 25(OH)D and free 25(OH)D were not different for any country (P>0.05). 
There were no country differences in the magnitude of the rhythm (assessed by CCV%) for DBP, 
albumin or free 25(OH)D and there were no consistent country differences between the other 
metabolites.  
In all countries, the strongest and most consistent cross correlation was between predicted values for 
DBP and albumin (all countries 0 hour time lag, r 0.94 – 0.98, P <0.0001 and DBP and total 1,25(OH)2D 
(all countries 0 hour time lag, all r 0.95 P <0.0001).   The cross correlation between total 25(OH)D and 
DBP was also highly significant (r 0.84 – 0.92; all P <0.0001) but the lag times were less consistent, 
varying between 0 and 3 hours, compared to cross correlation between DBP and total 1,25(OH)2D. We 
examined the cross correlation between PTH and total and free 1,25(OH)2D in each country (all P< 
0.0001) and found similar patterns for both total and free 1,25(OH)2D. 
 
4. Discussion 
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We have shown significant diurnal rhythms (DR) in total 25(OH)D, total 1,25(OH)2D, DBP, albumin 
and the free concentrations of both 25(OH)D and 1,25(OH)2D.  In this study, although the magnitude 
of the free 1,25(OH)2D DR was significant, it was attenuated compared to total 1,25(OH)2D as reflected 
by its smaller magnitude (CCV%).  This suggests that total and free 1,25(OH)2D concentrations respond 
to variation in DBP concentration and that the free 1,25(OH)2D concentration is maintained within a 
relatively narrow range through known feed-back mechanisms such as upregulation of CYP24A1, 
which catabolizes 1,25(OH)2D.  This is in accordance with the strict metabolic control of the circulating 
concentration of 1,25(OH)2D and the rapid feedback mechanism upon its activation of the VDR. There 
are reports of a DR of 1,25(OH)2D in some [9, 16] but not all human studies [17-19].  These differences 
may be due to the methods of analysis of the rhythm, sample size or the study population [16].  Only 
one study has reported a significant DR in the plasma concentrations of DBP, a study that showed no 
DRs in the calculated free-1,25(OH)2D index [16]. A single study has demonstrated a DR of 25(OH)D 
in humans [20]. 
Evidence of the potential influence of the DBP concentration on plasma of 1,25(OH)2D also comes 
from other human and animal studies. A significant positive association between plasma DBP and 
1,25(OH)2D concentration has been reported in a cohorts in Denmark [21] and Sweden [4] and in 
pregnancy an increase in DBP is associated with an increase in 1,25(OH)2D [22]. In DBP-null mice, 
circulating total 1,25(OH)2D was only 1% of that in the wild-type but cellular uptake and biological 
activity were not compromised [23] potentially because free 1,25(OH)2D is regulated and thus was 
maintained within narrow ranges.   
In contrast, there was no difference in the CCV% between total 25(OH)D and free 25(OH)D and the 
DR pattern of both total and free 25(OH)D poorly reflected that of the DRs of DBP and albumin. This 
indicates that free and total 25(OH)D do not respond as strongly as those of 1,25(OH)2D to changes in 
the plasma concentrations of its binding proteins, possibly because the concentration of free 25(OH)D 
is more dependent on 25(OH)D concentration than DBP concentration [24]. This is also consistent with 
the long plasma half-life of 25(OH)D (2 – 3 weeks) [25] and the limited metabolic control of the plasma 
concentration compared to 1,25(OH)2D that has a much shorter plasma half-life (~3 d) [26].  This 
observation may be surprising given that, of all the vitamin D metabolites, 25(OH)D has the highest 
affinity for DBP.   
The relationship between vitamin D metabolites and DBP and their free fractions may influence vitamin 
D availability, their half-lives and biological activity. Vitamin D metabolites are thought to be 
transported into cells predominantly by two mechanisms (1) DBP interaction and internalisation with 
the plasma membrane transporter protein, megalin, and (2) diffusion of the free metabolite across the 
cell membrane. In the kidney the megalin route is thought to be predominant but uptake of 25(OH)D 
into other cell types (e.g. monocytes [27]) is thought to be dependent on the diffusion of the free fraction. 
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These and many other cell types express CYP27B1 and can produce 1,25(OH)2D for intra- or paracrine 
effects.  Our understanding of the relative importance of these two mechanisms and their regulation in 
other tissue and cell types is in its infancy.   
The absence of a pronounced DR of free 1,25(OH)2D is of interest in the context of the rhythmicity of 
PTH and earlier reported significant cross correlations between PTH and total 1,25(OH)2D [9].  These 
data may imply that PTH regulates the production of total 1,25(OH)2D but may not influence its free 
fraction.  The latter may be predominantly controlled by feedback mechanisms upon VDR activation 
and/or the rate of 1,25(OH)2D internalisation and catabolism. There may be differences in the DRs of 
PTH and bone turnover markers in people with pathological conditions such as osteoporosis [28, 29] 
and diabetes [20] but this has so far not been shown for 1,25(OH)2D.  Plasma concentrations of 
1,25(OH)2D reflect the renal rather than the extra-renal production of 1,25(OH)2D.  Other cell types 
which express the CYP27B1 and CYP24A1 may produce and catabolize 1,25(OH)2D intracellularly 
and thus may have an independent DR. Further investigation is needed to understand whether systemic 
or intracellular rhythmicity are involved in the regulation of the circadian rhythm of bone remodelling 
and other cell types, such as adipose-derived stem cells [30, 31]. 
DBP and albumin exhibited significant DRs similar to those reported in previous studies [16, 32, 33] 
and their patterns were similar for all three groups. Since these two molecules have very different half-
lives (DBP ~ 2-3 d [34]; albumin ~ 20 d [35]) it is surprising that the DRs are similar and suggests that 
the DR in these plasma proteins may be related less to metabolism and more to other factors affecting 
their concentration.  For example, circadian rhythms in glomerular filtration rate may affect and 
influence the daily rhythm of higher molecular weight proteins such as albumin and DBP [33].  Also 
hydration status, posture and nocturnal haemodilution (whereby blood volume is greater at night than 
in the daytime [16]) may alter the volume of distribution, or transfer and the distribution between 
interstitial and intravascular fluid compartments. Such a change in dilution volume and tissue 
distribution could produce variability in plasma DBP and albumin concentration leading to variability 
in total 1,25(OH)2D concentration and maintenance of free 1,25(OH)2D.  
Fasting baseline and 24-hour mean concentrations of total 25(OH)D and total 1,25(OH)2D were higher 
in Gambian compared to British and Chinese participants. Elevated 1,25(OH)2D in Gambians is well 
documented and is probably related to their low dietary calcium intake and high PTH concentration as 
well as potentially the supply of 25(OH)D [9, 11, 36].  Lower plasma albumin in black populations has 
been observed previously in some studies in the US [37] and in previous comparative studies in The 
Gambia [38].  The lower albumin concentrations in Gambians may be due to genetic factors, higher 
levels of inflammation or lower dietary protein intake.  Slightly higher plasma albumin was reported in 
Asians in the US [39] but the reasons for the higher albumin in our Chinese group are unclear. Whist 
albumin circulates at much higher concentrations than DBP it’s contribution as a carrier of vitamin D 
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metabolites is relatively minor due to a much lower binding affinity.  Consequently, variation in 
calculated free 25(OH)D or 1,25(OH)2D concentration attributable to albumin is much lower than that 
of 25(OH)D, 1,25(OH)2D or DBP concentration.  For DBP concentrations, large differences between 
populations were influenced by the assay used for quantification [40] and data generated using other 
assays and mass spectrometric-based methods suggest less variation in DBP concentration due to race 
or genotype [5]. The timing of the peak and nadir of the DRs of DBP were similar between groups 
despite differences in lifestyle, diet and vitamin D status [9]. This suggests that these DRs are influenced 
by factors in common between countries, including those discussed above, and potentially an 
endogenous circadian component. Known environmental and genetic differences between groups did 
not appear to have an influence on the observation that the DR magnitudes were different between free 
1,25(OH)2D and total 1,25(OH)2D.  
This exploratory study has some limitations. DRs were calculated based on a limited number of data 
points and although, as much as practicable, participants were asked to follow their normal routines, by 
the nature of these types of studies this was not entirely possible [9].  By their nature, invasive studies 
of this type are relatively small and this study was no exception. The study results for each group may 
therefore not be fully representative of their respective populations. The use of calculated free 25(OH)D 
and 1,25(OH)2D for assessing free concentrations of vitamin D metabolites may only be suitable for 
use in healthy populations. Where vitamin D metabolite or DBP concentrations are significantly altered 
due to physiological or pathophysiological conditions they may be less applicable [6, 25, 41]. We used 
a calculation that includes concentrations of 25(OH)D, 1,25(OH)2D, DBP and albumin but did not 
consider DBP genotype. DBP genotype, by affecting binding affinity for 25(OH)D, is suggested to 
affect the free 25(OH)D concentration [13]. However, other studies have shown that there are no 
differences in the affinity of 25(OH)D for DBP (summarised in [24]).  Adjustment for DBP genotype 
would likely make only minor differences to the calculated free metabolite concentrations [13] and no 
difference to patterns within an individual.  
In conclusion, we have shown significant DRs in vitamin D metabolite and DBP concentrations. These 
data show the importance of standardisation of the timing of sample collection in studies. The 
significant correlation between 1,25(OH)2D and DBP and lower CCV% for free 1,25(OH)2D compared 
to total 1,25(OH)2D suggests that 1,25(OH)2D may respond to changes in DBP possibly to maintain 
free 1,25(OH)2D concentrations. In contrast, the DRs of total and free 25(OH)D appeared to be less 
influenced by DBP, suggesting that DBP has comparatively less effect on 25(OH)D concentration.  
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Figure 1. Vitamin D metabolites and their binding proteins exhibit significant diurnal rhythms that are attenuated 
for calculated free 1,25(OH)2D.  Diurnal rhythms were assessed in British (orange circles), Gambian (blue 
diamonds) and Chinese (green triangles) older people. Lines represent the fitted values following Fourier 
regression and the error bars 2 * the upper and lower standard error. 
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Table 1. Baseline participant characteristics and fasting, early-morning biochemistry 
 Britain (n 30) Gambia (n 31) China (n 30) 
Age, y 65.5 (3.9) 66.1 (4.3) 64.4 (3.5) 
Weight, kg 79.1 (73.3, 85.4)G**, C** 56.1 (53.1, 59.2)B**, C* 62.9 (60.1, 65.9)B**, C* 
Height, m 1.72 (0.11)G**, C* 1.62 (0.10)B** 1.64 (0.08)B* 
BMI, kg/m2 26.9 (25.0, 28.9)G**, C* 21.4 (10.5, 22.4)B** 23.0 (22.1, 24.0)B* 
Sex, female/male 14/16 17/14 14/16 
25(OH)D, nmol/L 37 (30,44)G** 59 (52, 65)B**, C** 32 (27, 38)G** 
1,25(OH)2D, pmol/L 124 (110, 140)G** 186 (172, 201)B**,C** 123 (110, 137)G** 
DBP, µmol/L 8.0 (7.5, 8.5)[n 29], G* 7.2 (6.9, 7.6)B* 7.8 (7.4, 8.2) 
Albumin, µmol/L 571 (557, 585)G**, C** 495 (481, 510)B**, C** 660 (646, 674)G**, C** 
Free 25(OH), pmol/L 11.1 (9.1, 13.4) [n 29],G** 19.5 (17.5, 21.8)B**, C** 9.7 (8.2, 11.4)G** 
Free 1,25(OH)2D, pmol/L 0.85 (0.76, 0.95)[
n 29],G** 1.42 (1.31, 1.54)B**, C** 0.83 (0.74, 0.93)G** 
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Table 2. Diurnal rhythm parameters 
 Britain (n 30) Gambia (n 31) China (n 30) 
25(OH)D 
24 h mean, nmol/L 37 (31, 43)G**, C* 62 (56, 69)B**, C** 29 (25, 35)B*, G** 
Rhythm significance, P 0.002 <0.0001 <0.0001 
CCV% 2.2 (1.1, 3.4)C* 3.0 (2.1, 3.8)C* 5.7 (3.5, 7.9)G*, B* 
1,25(OH)2D 
24 h mean, pmol/L 118 (105, 132)G** 183 (169, 198)B**, C** 116 (106, 127)G** 
Rhythm significance, P <0.0001 <0.0001 0.001 
%CCV 7.1 (6.3, 8.0)G**, C** 4.4 (3.5, 5.4)B** 3.8 (2.6, 4.9)B** 
DBP 
24 hour mean, µmol/L 7.8 (7.5, 8.2)G*, C* 7.2 (7.0, 7.5)B*, C* 7.4 (7.0, 7.7)B*, G* 
Rhythm significance, P <0.0001 0.001 <0.0001 
%CCV 4.5 (3.3, 5.6) 3.1 (1.9, 4.3) 4.8 (3.6, 6.0) 
Albumin 
24 hour mean, µmol/L 553 (544, 562)G*, C* 482 (472, 492)B*, C* 602 (589, 616)B*, G* 
Rhythm significance, P <0.0001 <0.001 <0.0001 
%CCV 4.1 (3.4, 4.7) 4.0 (3.4, 4.5) 4.7 (3.2, 6.2) 
Free 25(OH)D 
24 h mean, pmol/L 11.2 (9.7, 13.0)G** 20.8 (18.9, 22.9)B**, C** 9.4 (7.9, 11.3)G** 
Rhythm significance, P 0.008 0.005 0.1 
%CCV 2.6 (1.2, 4.1) 3.0 (1.7, 4.4) 3.1 (0.5, 5.7) 
Free 1,25(OH)2D 
24 h mean, pmol/L 0.83 (0.75, 0.92)G** 1.41 (1.30, 1.52)B**, C** 0.84 (0.76, 0.93)G** 
Rhythm significance, P <0.0001 0.01 0.04 
%CCV 3.2 (2.2, 4.2)G*,C* 1.4 (0.3, 2.6)B* 1.3 (0.1, 2.5)C* 
 
Values are geometric mean (95% CI). The CCV% (coefficient of cyclic variation) is the standardized magnitude 
of the rhythm. Free 25(OH)D and free 1,25(OH)2D parameters are based on are calculated values. Superscripts 
indicate differences between countries (B-Britain; G-Gambia; C-China); * P<0.05, ** P<0.001 
